Growing at the rate of 15% CAGR between 2018 to 2020, the pharma sector has made the PCD pharma franchise one of the brightest and most promising business opportunities for people who have a minimum of 2-5 years of experience in the pharma sector and especially for the pharma professionals willing to start their own business. PCD pharma franchise plays the role of a bridge between the producers or manufacturers who produce GMP DGCI products and the doctors, chemists, or pharmacists who generally generator the prescriptions of drugs and medicines.
For the PCD pharma franchise business to run smoothly, the selection of a good pharma company is very important. It is one of the first steps to start a pharma franchise business. There are many factors to be considered before choosing a pharma company. The reputation, market reach, ethical business policies, reasonable rate, transport and logistics facilities, and quality of the product and packaging are some of the boxes on the checklist.
However, with growing competition among the numerous emerging and existing pharma companies in India, it is not the easiest task to select the best pharma company for yourself. It requires a lot of research and considerations before selecting the pharma company for your franchise. It is always best to do all the research and decide for yourself rather than going with someone else’s suggestion or advice. Nonetheless, the article provides you with a fair idea of the best performing pharma company in India.
Lupin Limited
With one of the largest generic pharmaceutical revenue globally, Lupin Limited is an Indian multinational pharmaceutical company. Headquartered in Mumbai, Maharashtra, Lupin Limited is the world’s largest manufacturer of tuberculosis drugs which also manufactures medicines and drugs to treat diseases in various areas such as cardiovascular disease, asthma, diabetes, skin disease, etc.
The sixth-largest global pharmaceutical company that provides its PCD pharma franchise all over India, Lupin Limited came into existence in 1968. The founder of the company was a professor of chemistry at BITS-Pilani, Rajasthan, Dr. Desh Bandhu Gupta. The company first started manufacturing folic acid and iron tablets for the Government of India mother and child health program with the help of fundings from the Central Bank of India. After that, it went on to become the largest TB drug manufacturer in the world which at first constituted 36% of the company sales.
Lupin Limited as a company engages in the product development and manufacturing of almost the whole of the product range in the pharmaceutical industry which includes branded and generic formulations, advanced drug delivery systems, Active Pharmaceutical Ingredient, or API, and biotechnology. The Lupin Research Park located near Pune, the Research and Development program of the company houses more than 1400 scientists working in the Generic Research including both Process Research and Pharmaceuticals Research, Advanced Drug Delivery Systems (ADDS) Research, Intellectual Property Management, Novel Drug Discovery and Development (NDDD) and Biotechnology Research.
Lupin Limited is a company whose global presence can be felt quite easily as a company ventures in drugs transactions and productions in more than 70 countries which include developed market such as the USA, Europe, Japan, Australia and also potential emerging markets such as India, the Philippines, and South Africa to give examples.
The company’s US subsidiary, headquartered in Baltimore, Maryland, is the fifth largest and fastest-growing generics manufacturer in the country. The company also has a presence in the branded market. Lupin’s India Region Formulation (IRF) mainly targets lifestyle diseases and chronic disease therapy segments. In Europe, the company’s focus appears to be in the anti-infectives, cardiovascular, and CNS therapy areas. Lupin is also doing very well in the Japanese generic market. In 2014, Lupin entered into an agreement with Yoshindo Inc. to create YL biology (YLB) for conducting clinical trials. Although the company is doing quite well in many areas, antituberculosis remains its niche area making it a global leader in Cephatosporins, Cardiovascular, and the Anti-TB space.
Lupin Limited has its manufacturing facilities established and running across India, the USA, Mexico, and Brazil. A total of 15 facilities are certified and approved by an international regulatory organization such as US FDA, UK MHRA, TGA Australia, WHO, and the MCC South Africa. This ensures that the quality of their products is not easy to challenge. Their R&D teams are working continuously towards more effective in affordable development in the pharmaceutical industry.
The company’s policy of doing the ‘right thing’ in the ‘right manner’ at the ‘right time’ shows the dedication towards good corporate governance. The company formed P.L.E.D.G.E. (Preparing Lupin Employees to Demonstrate Governance and Ethical Conduct) which insurance proper treatment of the customers and business allies of the company by their employees. the company also promotes transparency and impartiality and sticks to the conventional norms of ethical, moral, and legal conduct in its business operations.
Because of its market share and reputation worldwide, many aspiring PCD owners are willing to take a franchise of Lupin Limited. They are also preferred for their excellent franchise training. The accurate, authoritative, and trustworthy information about their drugs and medicines help the franchise owner to know and promote the products better and help more people effectively and safely.